4868 RUE LEVY, SUITE 220, SAINT-LAURENT, A8
Annual Report to Security Holders
Investor Presentation
Announces Name Change to Therapeutics Inc.
enGene Holdings Inc. Enters Sales Agreement with Leerink Partners
Financial Results, Press Release
Second Amendment to Loan Agreement with Hercules Capital Executed
Announces Expanded $125 Million Debt Facility
Reports Full Year 2025 Financial Results and Provides Business Update
Q1
Amended Annual Report
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence